Schedule 13D ownership disclosure
BIOFRONTERA INC
Common Stock, par value $0.001 per share · CUSIP: 09077D209
Event date: 2024-12-20
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Biofrontera AG
Shares: 400,000.00 · Class: 5.16%
- Deutsche Balaton AktiengesellschaftReported CIK 0001571071
Shares: 458,884.00 · Class: 5.92%
- VV Beteiligungen Aktiengesellschaft
Shares: 458,884.00 · Class: 5.92%
- Delphi Unternehmensberatung AktiengesellschaftReported CIK 0001571070
Shares: 458,884.00 · Class: 5.92%
- Wilhelm Konrad Thomas Zours
Shares: 458,884.00 · Class: 5.92%
- Alexander Link
Shares: 458,884.00 · Class: 5.92%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-24-110979
- Form type
- SCHEDULE 13D/A
- Filer
- Biofrontera Inc.
- CIK
- CIK 1858685
- Filed
- Dec 20, 2024
- Reporting period
- Dec 20, 2024
- Description
- Schedule 13D beneficial ownership